Physician

Mark Pietro Seraly, MD

According to 2025 Medicare claims, Mark Seraly, MD (NPI: 1205396918) practices ophthalmology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is RETINA VITREOUS CONSULTANTS INC. (NPI: 1063444123; TIN: 251492985) and primary practice location at 26059-1022. Seraly is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Seraly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 98 traditional Medicare patients, billed 432 HCPCS/CPT codes, and received $41,839 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 278 prescription claims across 100 beneficiaries totaling $7,569 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 15 records totaling $430. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.